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ABSTRACT
Background: Dyspepsia is a symptoms collection of discomfort at the upper abdomen. Ramadan Fasting 
is a worship that must be run by all Moslems that do not eat and drink for ± 12 hours. Proton pump inhibitors 
are drugs commonly given to patients with dyspepsia with mechanism controlling gastric acid secretion. 
The aim of this study is to find the effect of omeprazole to the patient with dyspepsia and undergo Ramadan fasting.
Method: Using analytic study design, conducted in outpatient in Koja Hospital Jakarta from June - July 
2013, for patients with dyspepsia who will undergo Ramadan fasting. Subjects are divided into 2 groups; one 
group was given omeprazole while others were given a placebo. Before and after 2 weeks of fasting, dyspepsia 
symptoms severity index scores (DSSI) was taken which assessed changes in both groups and compared using 
student T-test.
Results: DSSI scores on average before the intervention of both groups (n = 30) was not significant 
(p = 0.9). In the placebo group obtained increasing of DSSI score from 27.7 ± 14 to 36 ± 14.8 (p = 0.001), 
whereas in the omeprazole group obtained increasing of score only from 27.2 ± 9.4 to 30 ± 9.9 (p = 0.08). 
In the placebo group score worsened by 8.3 ± 7.2 but in the omeprazole group with only 2.7 ± 5.7 (p = 0.02).
Conclusion: There was a significant decrease of DSSI scores in fasting patient with omeprazole. Therapy 
with omeprazole 20 mg twice daily during the month of fasting can reduce the abdominal complain in patient 
with dyspepsia.
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ABSTRAK
Latar belakang: Dispepsia adalah kumpulan gejala tidak nyaman pada perut bagian atas. Puasa Ramadan 
merupakan ibadah wajib bagi seluruh umat muslim dengan tidak minum atau makan selama ± 12 jam. 
Penghambat pompa proton merupakan obat yang umum diberikan pada pasien dispepsia dengan mekanisme 
kerja mengontrol sekresi asam lambung. Tujuan penelitian ini adalah untuk mengetahui pengaruh omeprazole 
terhadap keluhan pasien dispepsia yang sedang menjalankan ibadah puasa Ramadan.
Metode: Penelitian ini menggunakan desain penelitian analitik, dilakukan di Rumah Sakit Koja Jakarta 
sejak Juni hingga Juli 2013 terhadap semua pasien dispepsia yang akan menjalankan puasa Ramadan. Subyek 
dibagi menjadi 2 kelompok, dimana kelompok pertama diberi omeprazol selama menjalankan puasa, sedangkan 
kelompok lainnya diberi plasebo. Sebelum dan sesudah 2 minggu berpuasa dilakukan skoring dengan DSSI. 
Dinilai perubahan skor pada kedua kelompok kemudian dibandingkan menggunakan uji student T.
Hasil: Skor rata-rata sebelum intervensi (pre-test) kedua kelompok (n = 30) tidak ada perbedaan bermakna 
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(p = 0,9). Pada kelompok plasebo didapatkan peningkatan skor dari 27,7 ± 14 menjadi 36 ± 14,8 (p = 0,001), 
sedangkan kelompok dengan omeprazol didapatkan skor dari 27,2 ± 9,4 menjadi 30 ± 9,9 (p = 0,08). Perubahan 
skor rata-rata pada kelompok plasebo memburuk sebesar 8,3 ± 7,2 sedangkan kelompok dengan omeprazole 
hanya 2,7 ± 5,7 (p = 0,02). 
Simpulan: Terjadi penurunan skor DSSI yang bermakna pada kelompok yang menjalankan ibadah puasa 
dengan terapi omeprazole. Terapi omeprazole 20 mg dua kali sehari selama bulan puasa dapat mengurangi 
keluhan abdominal pasien dispepsia.
Kata kunci: dispepsia, DSSI, puasa, Ramadan
INTRODUCTION
Dyspepsia is a collection of symptoms or signs 
comprises of discomfort or pain in upper abdomen 
which persist or recur. Most commonly encountered 
symptoms are epigastric pain, epigastric discomfort, 
early satiety, fullness, bloating, and nausea.1,2 
Dyspepsia is a general gastrointestinal problem 
worldwide with highest prevalence found in New 
Zealand with 34.2%.1,3,4 National Health Department 
in the year 2004 placed dyspepsia in the 15th rank from 
50 list of diseases with most number of hospitalisation 
with proportion of 1.3%.5
Risk factors of dyspepsia include obesity, spicy 
food, cigarette, stress, coffee or tea, alcohol, irregular 
meal times, or even medicines, such as steroid and 
non-steroid anti inflammatory drugs (NSAIDS).6,7,8 
Ramadan fasting becomes one of the risk factors 
because during fasting in the Ramadan month, 
moslems do not eat and drink for 12-13 hours starting 
from sunrise until sunset.9,10,11 During fasting, gastrin, 
pepsin, and gastric acid secretion will increase.12 This 
gastric acid change may be the basis of increasing 
dyspepsia complaints during Ramadan.12
Question arises, does this Ramadan fasting 
influence the severity of dyspepsia in patients visiting 
Internal Medicine Outpatient Clinic in Koja Hospital. 
Degree of dyspepsia is evaluated clinically based on 
dyspepsia symptoms severity index (DSSI).13 DSSI is 
a questionnaire developed for screening in dyspepsia 
patients, which includes 20 questions comprises of 
dysmotility, reflux, and ulcer group of questions.13 
Endoscopic evaluations were not performed because 
in Ramadan month usually patients refuse to undergo 
invasive procedures.
METHOD
This study used analytic design, which was 
intervention study with double blind method, performed 
in Internal Medicine Outpatient Clinic of Koja Hospital, 
Jakarta from June 2013 until July 2013, with approval 
from the Ethics Committee of Health Study at Faculty 
of Medicine, University of Krida Wacana Christian, 
Jakarta. Sample collection method was non-probability 
sampling, which was concecutive sampling. Inclusion 
criteria were all patients diagnosed with dyspepsia who 
will perform fasting. While exclusion criteria included 
presence of ulcer or malignancy, dyspepsia caused by 
pancreatobilary and systemic disease, patient routinely 
received antiagregation medicine, NSAIDs for other 
diseases and pregnant patients.
All dyspepsia patients who fulfilled inclusion 
criteria were recorded, then they filled the DSSI 
questionnaire and were further divided into 2 groups 
through randomisation block. One of the groups was 
given omeprazole 20 mg twice daily during fasting, 
taken during the fast break and dawn, while other 
group was given placebo (vitamin B complex). 
Before and after fasting for two weeks, DSSI scoring 
evaluation was performed. DSSI score changes in both 
groups were assessed and compared using T-test with 
significant p value < 0.05 using SPSS version 21.0.
RESULTS
During 35 days of study, 30 patients with clinical 
complaints of dyspepsia who fulfilled inclusion criteria 
were chosen as study participants. Characteristics of 
chosen subjects were shown in Table 1.
To all subjects, DSSI score analysis was performed. 
Average of DSSI score before intervention (pre-test) 
in group A (without omeprazole) was 27.7 ± 14 
while in group B 27.2 ± 9.4 (p = 0.9). In group A to 
which omeprazole was not given during Ramadan 
fasting, worsening of DSSI score was obtained from 
27.7 ± 14 to 36 ± 14.8 (p = 0.001), while in group 
B to which omeprazole was given during Ramadan 
fasting, changes of DSSI score from 27.2 ± 9.4 to 30 
9.9 (p = 0.08) (Figure 1). Worsening of DSSI score 
after performing Ramadan fasting for 2 weeks was 
statistically significant with p = 0.001. On the other 
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hand, in group receiving omeprazole for prevention 
of dyspepsia, it was obtained that there was minor 
worsening, however not statistically significant.
Table 1. Dyspepsia patients characteristics (n = 30)
Characteristic Group An (%)
Group B
n (%)
Risk factors
Drugs 0 (0) 2 (13.3)
Irregular meal times 13 (86.7) 9 (60)
Alcohol 2 (13.3) 2 (13.3)
Coffee or tea 9 (60) 10 (66.7)
Stress 9 (60) 10 (66.7)
Cigarette 1 (6.7) 1 (6.7)
Spicy food 11 (73.3) 10 (66.66)
BMI (kg/m2)
 < 18.5 (underweight) 1 (6.7) 0 (0)
18.5 – 22.9 (normal) 6 (40) 7 (46.7)
23 – 24.9 (overweight) 3 (20) 1 (6.7)
25.0 – 29.9 (obese) 4 (26.7) 7 (46.7)
≥ 30 (very obese) 1 (6.7) 0 (0)
Clinical symptoms
Epigastric pain syndrome 3 (20) 3 (20)
Fullness/bloating (PDS) 1 (6.6) 3 (20)
Both 11 (73.7) 9 (60)
PDS: postprandial distress syndrome; Categorical data are presented in n 
(%) and numeric data are presented in mean [SD]
 
 
 
 
Figure 1. Mean of DSSI score pre-test and post-test in group 
A and B 
Additionally, average score changes (delta score) 
between pre-test and post-test was calculated in group 
A and B. In group A score worsened 8.3 ± 7.2 and 
in group B 2.7 ± 5.7 (p = 0.02). This difference was 
statistically significant. 
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Figure 2. Average score changes between pre-test and post-
test in group A and B
DISCUSSION
In the study performed to 30 patients diagnosed 
with dyspepsia in Internal Medicine Outpatient Clinic 
Koja Hospital, it was obtained that based on sex, 
number of female (73.33%) was greater compared 
to male (26.66%) in both groups. Most population 
studies revealed that there were no difference in the 
prevalence of dyspepsia based on sex, however some 
studies exhibited that the prevalence of dyspepsia was 
higher in female.14 Similarly, in the study conducted by 
Marwaha et al, it was reported that the prevalence of 
dyspepsia was higher in female.15 This might happen 
due to difference in nutrition, culture, socioeconomic, 
and hormonal.
Based on complaints from patients' history taking, 
it was recorded that 6 (20%) patients complained of 
epigastric pain syndrome (EPS), 4 (13.33%) patients 
complained of postprandial distress syndrome (PDS), 
and 20 (66.66%) patients complained of both (EPS 
+ PDS). This result differed from that of the study 
performed by Nwokediuko et al in Nigeria which 
obtained results of EPS, PDS, and EPS + PDS 
with presentation of 79.2%, 62.5% and 50%.16 This 
difference may be caused by ethnical difference or 
methods in data collection.
In the study performed by Li et al in China, highest 
prevalence of dyspepsia was the age group of 41–50 
year old17 and in the study in Japan, highest prevalence 
was in the age group of 50–59 year old.14 In this study, 
highest prevalence was in the age group of 51–60 
year old (30% patients) where it was in concordance 
with the study in Japan. Variations of age group in 
different studies might be caused by environmental 
and nutritional factors, or even in drugs consumed. 
Many risk factors influence the presence of 
dyspepsia complaints. Every patient may has more than 
one risk factor. In this study, most risk factors obtained 
was irregular meal as much as 73.33%. This study 
agreed with the study performed by Annisa, where 
there was relationship between meals irregularity with 
dyspepsia syndrome.18
Average of DSSI score in pre-test and post-test 
in both groups showed increased score in group A 
(as much as 8.4) which was much higher compared 
to group B (as much as 2.7). This result showed that 
there was increase of gastric acid which happened 
during fasting in Ramadan month and influenced 
the presence of worsening in dyspepsia complaints. 
In accordance to the study performed by Iraki et 
al which studied the decrease of gastric pH during 
fasting in Ramadan month, it was known that gastric 
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pH decreased significantly after day-10 of Ramadan 
fasting compared to the gastric acid level before 
fasting.9
The difference of DSSI score in group A compared 
to group B after intervention and Ramadan fasting 
for 2 weeks revealed higher score improvement in 
group B compared to group A. This difference was 
statistically significant, because obtained p = 0.02. This 
result showed that administration of omeprazole 20 mg 
twice daily to dyspepsia patients who will do fasting 
is beneficial in preventing worsening of dyspepsia 
complaints.
Limitations of this study mainly were small sample 
size and short duration of data collection. Limited 
sample size was caused by difficulty in collecting 
samples and number of dropouts due to several factors, 
such as menstruation in female, not performing fasting 
completely during the period of the study; hence, those 
samples were not included in the study.
CONCLUSION
From the study which has been performed, it was 
found that dyspepsia patients were mostly females, 
most notable complaints were combination of 
epigastric pain and fullness/bloating (EPS + PDS), and 
most frequent risk factor of dyspepsia was irregular 
meal timings. There was significant decrease of DSSI 
score in study subjects who performed fasting and 
consumed omeprazole.
Similar study could be done better by collecting 
more samples to obtain optimal results and it was 
expected that this study can be applied in medical 
practice as part of management in dyspepsia patients 
who will perform Ramadan fasting.
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